Knome and Personal Genomics to Form Sales Alliance and Scientific Partnership
CAMBRIDGE, MA, USA, April 11, 2014 – Knome, Inc. and Personal Genomics, s.r.l., Verona, Italy, announced an exclusive sales alliance for Knome’s knoSYS™ platform in Italy and a scientific partnership for continued development of the platform’s tools, content, and applications.
Knome offers the fully integrated knoSYS platform for the management and interpretation of human genome sequence data. The knoSYS systems combine analytical and workflow software with powerful grid computers. Earlier in this year Knome expanded its line of models. In addition to the initial knoSYS™100 model designed for high throughput genomics, Knome now offers a smaller system, the knoSYS™25, designed for labs working mostly on targeted panels and moderate numbers of exomes and genomes.
Prof. Massimo Delledonne of the Università degli Studi di Verona was one of the first to purchase and work with the flagship knoSYS™100 model. “As one of the first academic whole genome and personal genomics labs in Italy, we were looking for a secure and fast computing environment for all our genomic data processing.” Prof. Delledonne said.
After last year’s launch of the knoSYS platform, Knome immediately started to search for strategic distribution partners. “We were impressed by the deep expertise we found in Personal Genomics, in genomics as well as in high performance computing, a rare combination that is central to Knome’s approach to addressing the burgeoning clinical sequencing market” said Wolfgang Daum, CEO of Knome. “Prof. Delledonne’s confidence in Knome’s system and their professional team convinced us to become Knome’s first international distributor” said Marco Dotto, CEO of Personal Genomics.
About Knome
Knome Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Designed to accelerate and industrialize the process of interpreting whole genomes, Knome’s big data technologies are helping to pave the healthcare industry’s transition to molecular-based, precision medicine. www.knome.com.
For more information about Knome visit www.knome.com, or contact Jorge Conde, [email protected], +1-617-715-1000 x2001.
About Personal Genomics
Personal Genomics s.r.l. is a leading provider of genomics services for the Italian market. It provides Next Generation Sequencing and genome interpretation services to researchers and clinicians offering the best tools for personalized medicine and pharmacogenomics. The company’s mission is to apply translational genomics and its exponential growth to the real world of patient care and precision medicine. Personal Genomics aims to reduce the gap between the disruptive scientific and technological progress developed in research labs and the applications in the healthcare industry to improve people’s life.
For more information about Personal Genomics visit www.personalgenomics.it/en, or contact Marco Dotto, [email protected], +39-045-8027834.
###